Skip to search formSkip to main contentSkip to account menu

reboxetine

Known as: reboxetine [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND AND PURPOSE The tail of the ventral tegmental area (tVTA), also called the rostromedial tegmental nucleus, is a newly… 
Highly Cited
2008
Highly Cited
2008
OBJECTIVE The aim of the present study was to examine the influence of reboxetine and mirtazapine on psychomotor functions… 
Highly Cited
2008
Highly Cited
2008
Recent neuropsychological studies in healthy volunteers suggest that antidepressants enhance the processing of positive emotional… 
Review
2005
Review
2005
Objective:  The present study uses the data from a large survey conducted to examine the general practice of Spanish… 
2001
2001
The negative symptoms of schizophrenia remain a major clinical challenge. Reboxetine is an antidepressant whose major mechanism… 
2000
2000
&NA; Controlled trials in patients with bulimia nervosa have demonstrated efficacy of antidepressant medications with… 
Highly Cited
1996
Highly Cited
1996
Reboxetine is a novel antidepressant that has been shown to be effective in the treatment of major depressive disorders. The… 
1995
1995
1. The aim of the study was to examine the effects of single doses of two antidepressants (desipramine and reboxetine) on three…